Polymyositis-dermatomyositis and non-Hodgkin's lymphoma.
An association between polymyositis-dermatomyositis (PM/DM) and malignancy has been reported. However, controversy exists regarding a direct causal relationship between the two diseases. We describe a patient who had had PM and subsequently developed non-Hodgkin's lymphoma, and discuss the possibility of their causal relation.
Endo
T
T
First Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
Kawaguchi
N
N
Yashima
M
M
Tei
H
H
Hayakawa
H
H
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003882:Dermatomyositis / Q000150:complications*; D004317:Doxorubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008228:Lymphoma, Non-Hodgkin / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D017285:Polymyositis / Q000150:complications*; D011241:Prednisone / Q000008:administration & dosage; D011859:Radiography; D014750:Vincristine / Q000008:administration & dosage; D014786:Vision Disorders / Q000150:complications
D001761:Bleomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D002955:Leucovorin; D011241:Prednisone; D008727:Methotrexate